A Comparative Analysis on the Efficacy and Safety of Intaxel® and Taxol® in Advanced Metastatic Breast Cancer

Background: Among the presently available cytotoxic drugs, paclitaxel, in combination with doxorubicin and carboplatin, come under the highly active therapy for metastatic breast cancer. Between the two brands of paclitaxel (Intaxel, which is marketed by Fresenius Kabi and Taxol, the original paclit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lang, Istvan, Rubovszky, Gabor, Horvath, Zsolt, Ganofszky, Erna, Szabo, Eszter, Dank, Magdolna, Boer, Katalin, Hitre, Erika
Formato: Artigo
Idioma:Inglês
Publicado em: JCDR Research and Publications (P) Limited 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708212/
https://ncbi.nlm.nih.gov/pubmed/23905117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2013/4742.3027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados